FUSIONQUANT

Dead / Cancelled — Cancelled — Section 8 (as of 09 Oct 2015)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
78249512
Registration number
2930568
Mark type
Word mark
Filed
14 May 2003
Published for opposition
14 Dec 2004
Registered
08 Mar 2005
Attorney of record
Barry L. Kelmachter

Goods and services

  • Class 005 — Pharmaceuticals: Diagnostic biological reagents for clinical or medical laboratory use or for determining gene translocations with partner genes which lead to neurological illness, muscular dystrophy, autism, schizophrenia, Down syndrome, leukemia, lymphoma, melanomas of soft parts, liposarcoma, Ewings sarcoma, neuroectodermal tumors, myelodysplastic syndromes, chondrosarcoma, desmoplastic small round cell tumor, rhabdomyosarcoma, non-Hodgkins lymphoma, myeloproliferative disorders, cogenital fibrosarcoma, nephromas, multiple myelomas, parathyroid ademnomes, parathyroid neoplasms, adenomas, lymphoproliferative disorders, plasma cell malignancies, Burkitt lymphoma, meningiomas, dermatofibrosarcoma protuberans, papillary carcinoma, cemento ossifying fibromas of the orbit, orbital neoplasms, ossifying fibromas, salivary gland neoplasms, pleomorphic adenomas, lipomas, hamartomas, uterine neoplasms, leiomyomas, osteosarcomas, cultured tumor cells, neuroblastomas, plasma cell granulomas, papillary renal cell carcinomas, kidney neoplasms, renal cell carcinomas, papillary carcinomas, follicular adenocarcinomas, endometrial neoplasms, follicular lymphomas, glioblastomas, splenic neoplasms, lung neoplasms, squamous cell carcinomas, giant cell fibroblastoma, Bednar tumors, giant cell carcinomas, skin neoplasms, lipoblastomas, ganglioneuroblastomas, breast neoplasms, hypereosinophilic syndrome, synovial sarcoma; pharmaceutical preparations for treatment of muscular dystrophy, autism, schizophrenia, Down syndrome, leukemia, lymphoma, melanomas of soft parts, liposarcoma, Ewings sarcoma, neuroectodermal tumors, myelodysplastic syndromes, chondrosarcoma, desmoplastic small round cell tumor, rhabdomyosarcoma, non-Hodgkins lymphoma, myeloproliferative disorders, cogenital fibrosarcoma, nephromas, multiple myelomas, parathyroid ademnomes, parathyroid neoplasms, adenomas, lymphoproliferative disorders, plasma cell malignancies, Burkitt lymphoma, meningiomas, dermatofibrosarcoma protuberans, papillary carcinoma, cemento ossifying fibromas of the orbit, orbital neoplasms, ossifying fibromas, salivary gland neoplasms, pleomorphic adenomas, lipomas, hamartomas, uterine neoplasms, leiomyomas, osteosarcomas, cultured tumor cells, neuroblastomas, plasma cell granulomas, papillary renal cell carcinomas, kidney neoplasms, renal cell carcinomas, papillary carcinomas, follicular adenocarcinomas, endometrial neoplasms, follicular lymphomas, glioblastomas, splenic neoplasms, lung neoplasms, squamous cell carcinomas, giant cell fibroblastoma, Bednar tumors, giant cell carcinomas, skin neoplasms, lipoblastomas, ganglioneuroblastomas, breast neoplasms, hypereosinophilic syndrome, synovial sarcoma

Owner

Prosecution history

  • 09 Oct 2015 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
  • 21 Mar 2011 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 18 Mar 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 03 Mar 2011 — TEAS SECTION 8 & 15 RECEIVED
  • 08 Mar 2005 — REGISTERED-PRINCIPAL REGISTER
  • 14 Dec 2004 — PUBLISHED FOR OPPOSITION
  • 24 Nov 2004 — NOTICE OF PUBLICATION
  • 08 Oct 2004 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 06 Oct 2004 — ASSIGNED TO LIE
  • 30 Sept 2004 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 15 Sept 2004 — AMENDMENT FROM APPLICANT ENTERED
  • 26 Aug 2004 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 26 Aug 2004 — Sec. 1(B) CLAIM DELETED
  • 26 Aug 2004 — PAPER RECEIVED
  • 23 Jun 2004 — LETTER OF SUSPENSION E-MAILED

View this trademark record on Marksy